Loading
Latest filing published 17 Aug 2023 for Protalix BioTherapeutics, Inc..
No signal scores available.
Yael Hayon has a single filing on record, published on 17 August 2023: a share grant in Protalix BioTherapeutics, Inc. One trade is not enough to describe a pattern. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration